Related Experiment Video
Updated: Aug 13, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
The future of pharmacoeconomics: a commentary
1Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, USA.
Clinical Therapeutics
|July 1, 1997
Summary
The future of pharmacoeconomics depends on modeling new drug impacts to meet healthcare decision-makers' needs. Clinical trials provide essential data but modeling is the core task for this discipline.
Area of Science:
- Pharmacoeconomics
- Health Economics
- Health Services Research
Background:
- Dr. Michael F. Drummond proposed that pharmacoeconomics should focus on both trial-based and modeling studies.
- This commentary presents an alternative perspective on the future direction of pharmacoeconomics.
- The discipline's survival hinges on its ability to meet the practical needs of decision-makers in healthcare.
Purpose of the Study:
- To propose an alternative future for pharmacoeconomics, emphasizing the central role of modeling.
- To argue that modeling new drug impacts is the principal task for pharmacoeconomists.
- To reframe the importance of clinical trials as inputs for modeling, rather than the primary focus.
Main Methods:
- This is a commentary, presenting a conceptual argument and alternative scenario.
- It critiques the view that both trial-based and modeling studies are equally future-oriented.
- It emphasizes the practical application of pharmacoeconomic research for decision-making.
Main Results:
- The core task for pharmacoeconomists should be the modeling of new drug impacts.
- Clinical trials are valuable inputs but not the defining future of the discipline.
- Meeting decision-makers' needs through effective modeling is crucial for pharmacoeconomics' viability.
Conclusions:
- The future of pharmacoeconomics is intrinsically linked to its ability to model the impact of new therapies.
- Effective modeling, driven by data from clinical trials, is essential for informing healthcare decisions.
- For pharmacoeconomics to remain a meaningful discipline, its focus must shift towards modeling and decision support.
Related Concept Videos
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:21Pharmacodynamics: Overview and Principles
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).